These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 582772

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B, Grünberger J, Linzmayer L.
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [Abstract] [Full Text] [Related]

  • 3. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
    Saletu B, Grünberger J, Linzmayer L.
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
    [Abstract] [Full Text] [Related]

  • 4. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
    Saletu B, Barbanoj MJ, Anderer P, Sieghart W, Grünberger J.
    Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
    [Abstract] [Full Text] [Related]

  • 5. [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].
    Saletu B, Grünberger L, Linzmayer L, Wittek R, Stöhr H.
    Wien Klin Wochenschr; 1983 Jul 08; 95(14):481-93. PubMed ID: 6356628
    [Abstract] [Full Text] [Related]

  • 6. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.
    Saletu B, Grünberger J, Linzmayer L, Anderer P.
    Pharmacopsychiatry; 1987 Feb 08; 20(1 Spec No):12-27. PubMed ID: 2883677
    [Abstract] [Full Text] [Related]

  • 7. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
    Saletu B, Grünberger J, Linzmayer L, Stöhr H.
    Int J Clin Pharmacol Res; 1984 Feb 08; 4(2):95-107. PubMed ID: 6469443
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.
    Saletu B, Grünberger J, Linzmayer L.
    Methods Find Exp Clin Pharmacol; 1980 Oct 08; 2(5):269-85. PubMed ID: 6927816
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Classification and assessment of cerebral bioavailability of lopirazepam (D-12524) by quantitative EEG and psychometric analysis.
    Saletu B, Grünberger J, Linzmayer L, Stadler R.
    Arzneimittelforschung; 1980 Oct 08; 30(3):513-8. PubMed ID: 6104496
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effect of flurazepam, brotizolam and alcohol on psychomotor performance.
    Krueger H.
    Arzneimittelforschung; 1986 Mar 08; 36(3A):616-20. PubMed ID: 3718586
    [Abstract] [Full Text] [Related]

  • 13. Classification and determination of cerebral biovailability of psychotropic drugs by quantitative "pharmaco-EEG" and psychometric investigations (studies with AX-A411-BS).
    Saletu B, Grünberger J, Linzmayer L.
    Int J Clin Pharmacol Biopharm; 1977 Oct 08; 15(10):449-59. PubMed ID: 21853
    [Abstract] [Full Text] [Related]

  • 14. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.
    Saletu B, Grünberger J, Linzmayer L, Dubini A.
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct 08; 21(10):489-95. PubMed ID: 6139346
    [Abstract] [Full Text] [Related]

  • 15. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B, Grünberger J, Anderer P, Linzmayer L, König P.
    Arzneimittelforschung; 1995 Mar 08; 45(3):217-29. PubMed ID: 7741773
    [Abstract] [Full Text] [Related]

  • 16. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B, Anderer P, Wolzt M, Nosiska D, Assandri A, Noseda E, Nannipieri F, Saletu-Zyhlarz GM.
    Neuropsychobiology; 2009 Mar 08; 59(2):110-22. PubMed ID: 19365151
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.
    Saletu B, Grünberger J.
    Methods Find Exp Clin Pharmacol; 1985 Mar 08; 7(3):137-51. PubMed ID: 4010387
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of triazolam, flurazepam and placebo as hypnotic agents in pre-surgical patients.
    Matta B, Franco AE, Le Zotte LA, Rudzik AD, Veldkamp W.
    Curr Ther Res Clin Exp; 1974 Sep 08; 16(9):958-63. PubMed ID: 4214670
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.